SU Wei-peng,ZHAO Hua-rong,LIU Pan,et al.The role of poly ADP-ribose polymerase-1 in oxidative DNA damage and apoptosis of laryngeal squamous cell carcinoma cells[J].JOURNAL OF REGIONAL ANATOMY AND OPERATIVE SURGERY,2023,32(08):666-672.
SU Wei-peng,ZHAO Hua-rong,LIU Pan,et al.The role of poly ADP-ribose polymerase-1 in oxidative DNA damage and apoptosis of laryngeal squamous cell carcinoma cells[J].JOURNAL OF REGIONAL ANATOMY AND OPERATIVE SURGERY,2023,32(08):666-672. DOI: 10.11659/jjssx.08E022029.
The role of poly ADP-ribose polymerase-1 in oxidative DNA damage and apoptosis of laryngeal squamous cell carcinoma cells
To investigate the expression of poly ADP-ribose polymerase-1 (PARP1) in laryngeal squamous cell carcinoma (LSCC) and its effect on DNA oxidative damage and apoptosis of LSCC cells.
Methods
2
LSCC tissue and paracancerous tissue samples from 40 patients were collected. Immunohistochemical staining and qRT-PCR were used to detect the expression of PARP1 in LSCC tissue and paracancerous tissue. LSCC cell line Hep-2 was induced by different concentrations of Menadione, and the inhibition rate of cell proliferation was detected by MTT assay. The Hep-2 cells were randomly divided into the control group(normal culture), Men group (treated with 20 μmol/L Menadione), Men+PARP1 inhibitor group (co-treated with 20 μmol/L Menadione and 10 μmol/L PARP-1 inhibitor Olaparib), the inhibition rate of cell proliferation was calculated by MTT assay, the intracellular reactive oxygen species (ROS) levels in each group was detected by flow cytometry, the focus formation of DNA damage marker γ-H2AX in each group was observed by immunofluorescence staining, the protein expression of γ-H2AX, DNA-PKcs, BRCA1, LIG4, Caspase-3 and Caspase-9 in each group were determined by Western blot, the apoptosis in each group was observed by Hoechst33258 staining.
Results
2
The positive expression rate of PARP1 and the relative expression of PARP1 mRNA in LSCC tissues were significantly higher than those in paracancerous tissue (
P
<
0.01). The proliferation inhibition rates of Hep-2 cells after induced by different concentration of Menadione were increased (
P
<
0.05).Compared with the control group, the inhibition rates of cell proliferation in the Men group and the Men+PARP1 inhibitor group were increased, the levels of ROS were increased, the formations of γ-H2AX foci were significantly increased, and the relative protein expression of γ-H2AX protein were up-regulated, the relative protein expression of DNA-PKcs, BRCA1 and LIG4 were all down-regulated, the cells appeared condensed and fragmented blue apoptotic bodies appeared in cells, the relative protein expression of Caspase-3 and Caspase-9 were down-regulated, the differences were statistically significant (
P
<
0.05); and the above changes were more significant in the Men+PARP1 inhibitor group than in the Men group (
P
<
0.05).
Conclusion
2
PARP1 is highly expressed in LSCC tissue, which can further aggravate Menadione-induced DNA oxidative damage of Hep-2 cells and promote apoptosis after inhibited.
Bray F,Ferlay J,Soerjomataram I,et al.Global cancer statistics 2018:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CA Cancer J Clin,2018,68(6):394-424.doi:10.3322/caac.21492http://dx.doi.org/10.3322/caac.21492.
Steuer CE,El-Deiry M,Parks JR,et al.An update on larynx cancer[J].CA Cancer J Clin,2017,67(1):31-50.doi:10.3322/caac.21386http://dx.doi.org/10.3322/caac.21386.
Farlow JL,Brenner JC,Lei YL,et al.Immune deserts in head and neck squamous cell carcinoma:a review of challenges and opportunities for modulating the tumor immune microenvironment[J].Oral Oncol,2021,120:105420.doi:10.1016/j.oraloncologyhttp://dx.doi.org/10.1016/j.oraloncology.
Siegel RL,Miller KD,Fuchs HE,et al.Cancer Statistics,2021[J].CA Cancer J Clin,2021,71(1):7-33.doi:10.3322/caac.21654http://dx.doi.org/10.3322/caac.21654.
Kim C,Chen C,Yu Y.Avoid the trap:targeting PARP1 beyond human malignancy[J].Cell Chem Biol,2021,28(4):456-462.doi:10.1016/j.chembiol.2021.02.004http://dx.doi.org/10.1016/j.chembiol.2021.02.004.
Ray Chaudhuri A,Nussenzweig A.The multifaceted roles of PARP1 in DNA repair and chromatin remodelling[J].Nat Rev Mol Cell Biol,2017,18(10):610-621.doi:10.1038/nrm.2017.53http://dx.doi.org/10.1038/nrm.2017.53.
Kontandreopoulou CN,Diamantopoulos PT,Tiblalexi D,et al.PARP1 as a therapeutic target in acute myeloid leukemia and myelodysplastic syndrome[J].Blood Adv,2021,5(22):4794-4805.doi:10.1182/bloodadvances.2021004638http://dx.doi.org/10.1182/bloodadvances.2021004638.
Zhang X,Wang Y,A GR,et al.Pan-cancer analysis of PARP1 alterations as biomarkers in the prediction of immunotherapeutic effects and the association of its expression levels and immunotherapy signatures[J].Front Immunol,2021,12:721030.doi:10.3389/fimmu.2021.721030http://dx.doi.org/10.3389/fimmu.2021.721030.
Rajawat J,Shukla N,Mishra DP.Therapeutic targeting of poly(ADP-ribose) polymerase-1 (PARP1) in cancer:current developments,therapeutic strategies,and future opportunities[J].Med Res Rev,2017,37(6):1461-1491.doi:10.1002/med.21442http://dx.doi.org/10.1002/med.21442.
Manchana T,Phoolcharoen N,Tantbirojn P.BRCA mutation in high grade epithelial ovarian cancers[J].Gynecol Oncol Rep,2019,29:102-105.doi:10.1016/j.gore.2019.07.007http://dx.doi.org/10.1016/j.gore.2019.07.007.
Tumban E.A current update on human papilloma virus-associated head and neck cancers[J].Viruses,2019,11(10):922.doi:10.3390/v11100922http://dx.doi.org/10.3390/v11100922.
Ji X,Sui L,Song K,et al.PD-L1,PARP1,and MMRs as potential therapeutic biomarkers for neuroendocrine cervical cancer[J].Cancer Med,2021,10(14):4743-4751.doi:10.1002/cam4.4034http://dx.doi.org/10.1002/cam4.4034.
Dutta P,Paico K,Gomez G,et al.Transcriptional regulation of CL2 by PARP1 is a driver for invasiveness in breast cancer[J].Cancers (Basel),2020,12(5):1317.doi:10.3390/cancers12051317http://dx.doi.org/10.3390/cancers12051317.
Kupczyk P,Simiczyjew A,Marczuk J,et al.PARP1 as a marker of an aggressive clinical phenotype in cutaneous melanoma:a clinical and an in vitro study[J].Cells,2021,10(2):286.doi:10.3390/cells10020286http://dx.doi.org/10.3390/cells10020286.
de Almeida LC,Calil FA,Machado-Neto JA,et al.DNA damaging agents and DNA repair:from carcinogenesis to cancer therapy[J].Cancer Genet,2021,252/253:6-24.doi:10.1016/j.cancergen.2020.12.002http://dx.doi.org/10.1016/j.cancergen.2020.12.002.
Majiene D,Kuseliauskyte J,Stimbirys A,et al.Comparison of the effect of native 1,4-Naphthoquinones plumbagin,menadione,and lawsone on viability,Redox status,and mitochondrial functions of C6 glioblastoma cells[J].Nutrients,2019,11(6):1294.doi:10.3390/nu11061294http://dx.doi.org/10.3390/nu11061294.
Fong PC,Boss DS,Yap TA,et al.Inhibition of poly(ADP-ribose) polymerase in tumors from BRCA mutation carriers[J].N Engl J Med,2009,361(2):123-134.doi:10.1056/NEJMoa0900212http://dx.doi.org/10.1056/NEJMoa0900212.
Noubissi FK,McBride AA,Leppert HG,et al.Detection and quantification of γ-H2AX using a dissociation enhanced lanthanide fluorescence immunoassay[J].Sci Rep,2021,11(1):8945.doi:10.1038/s41598-021-88296-3http://dx.doi.org/10.1038/s41598-021-88296-3.
Yang H,Yao F,Marti TM,et al.Beyond DNA repair:DNA-PKcs in tumor metastasis,metabolism and immunity[J].Cancers (Basel),2020,12(11):3389.doi:10.3390/cancers12113389http://dx.doi.org/10.3390/cancers12113389.
Martinez AR,Kaul Z,Parvin JD,et al.Differential requirements for DNA repair proteins in immortalized cell lines using alternative lengthening of telomere mechanisms[J].Genes Chromosomes Cancer,2017,56(8):617-631.doi:10.1002/gcc.22465http://dx.doi.org/10.1002/gcc.22465.
Cartwright IM,Liu X,Zhou M,et al.Essential roles of Caspase-3 in facilitating Myc-induced genetic instability and carcinogenesis[J].Elife,2017,6:e26371.doi:10.7554/eLife.26371http://dx.doi.org/10.7554/eLife.26371.
Zhang J,Kodali S,Chen M,et al.Maintenance of germinal center B cells by Caspase-9 through promotion of apoptosis and inhibition of necroptosis[J].J Immunol,2020,205(1):113-120.doi:10.4049/jimmunol.2000359http://dx.doi.org/10.4049/jimmunol.2000359.